William W Brooke bought MXCT once, on Aug 13, 2025

Brooke William W (William W. Brooke) is a corporate insider and individual who serves as a non‑employee Director of MaxCyte, Inc. (NASDAQ: MXCT), a role in which he has been actively involved in the company’s governance and equity‑based compensation programs.( As a MaxCyte director, he has reported multiple insider transactions, including equity awards of 30,421 restricted stock units and 49,579 stock options in June 2025, and subsequent common‑stock purchases that brought his direct holdings to more than 150,000 shares.(

Professionally, Brooke has a long tenure as an independent non‑executive director at MaxCyte dating back to 2004, alongside board roles at organizations such as the Alabama Symphony Orchestra and KPX Global LLC.( He is the founder of HMC‑Virginia, Inc., where he served as Managing Partner from 1993 to 2011, and also founded the law firm Wallace, Jordan, Ratliff & Brandt LLC, reflecting a career that spans investment management, corporate governance, and legal practice.( Earlier, he served as Executive Vice President at Harbert Management Corp. and held directorships at multiple healthcare and technology companies, including Atherotech, NovaMin Technology, nContact Surgical, Innovative Biosensors, Emageon, and Aldagen, among others.( Brooke holds both undergraduate and graduate degrees from The University of Alabama, providing the academic foundation for his leadership in finance, health technology, and corporate oversight.(

Written by Perplexity from public sources.